Hamideh Moravvej Farshi (Hamideh Moravvej, H Moravvej)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Metastatic Renal Cell Carcinoma

Respiratory Syndrome Coronavirus

Extracellular Matrix

Top Venues

Clinical case reports

Dermatologic therapy

Archives of Iranian medicine

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Farnaz Araghi, Farideh Beyki, Azadeh Rakhshan, Hamideh Moravvej Farshi
Generalized lichen planus pigmentosus and a new management approach. Clinical case reports 12 (6) (2024)
Farnaz Araghi, Farideh Beyki, Azadeh Rakhshan, Hamideh Moravvej Farshi
Generalized lichen planus pigmentosus and a new management approach. Clinical case reports 12 (6) (2024)
Nima Sarisarraf, Farnaz Araghi, Zahra Asadikani, Hamideh Moravvej Farshi
Invasive squamous cell carcinoma on sternotomy scar. Clinical case reports 12 (4) (2024)
Nima Sarisarraf, Farnaz Araghi, Zahra Asadikani, Hamideh Moravvej Farshi
Invasive squamous cell carcinoma on sternotomy scar. Clinical case reports 12 (4) (2024)
Toktam Safari Giv, Ghazal Mardani, Azadeh Rakhshan, Mohammad Kouhestany, Hamideh Moravvej Farshi
An unusual case of granulomatosis with polyangiitis with unilateral parotid gland enlargement. Clinical case reports 11 (11) (2023)
Reem Diab, Farnaz Araghi, Mehdi Gheisari, Zahra Asadi Kani, Hamideh Moravvej Farshi
Lichen planus and lichen planopilaris flare after COVID-19 vaccination. Dermatologic therapy 35 (3) (2022)
Saeed Aref, Sara Nouri, Hamideh Moravvej Farshi, Mojtaba Memariani, Mojtaba Memariani
Epidemiology of Dermatophytosis in Tehran, Iran: A Ten-year Retrospective Study. Archives of Iranian medicine 25 (8) (2022)
Fahimeh Abdollahimajd, Mohammad Reza Pourani, Hamid Mahdavi, Hamid Mirzadeh, Shima Younespour, Hamideh Moravvej Farshi
Efficacy and safety of chitosan-based bio-compatible dressing versus nanosilver (Acticoat TM ) dressing in treatment of recalcitrant diabetic wounds: A randomized clinical trial. Dermatologic therapy 35 (9) (2022)
Forough Shams, Azam Rahimpour, Hassan Vahidnezhad, Simzar Hosseinzadeh, Hamideh Moravvej Farshi, Bahram Kazemi, Masoumeh Rajabibazl, Fahimeh Abdollahimajd, Jouni Uitto
The utility of dermal fibroblasts in treatment of skin disorders: A paradigm of recessive dystrophic epidermolysis bullosa. Dermatologic therapy 34 (4) (2021)
Hamideh Moravvej Farshi, Mojtaba Memariani, Mojtaba Memariani, Maryam Kabir-Salmani, Alireza Shoae-Hassani, Fahimeh Abdollahimajd
Evaluation of Fibroblast Viability Seeded on Acellular Human Amniotic Membrane. BioMed research international 2021 (2021)
Hamideh Moravvej Farshi, Mohammad Reza Pourani, Moein Baghani, Fahimeh Abdollahimajd
Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens. Dermatologic therapy 34 (4) (2021)
Fahimeh Abdollahimajd, Maryam Beheshti, Hamideh Moravvej Farshi
Evaluation of the efficacy and safety of plasma exeresis in periorbital rejuvenation using the Reviscometer®. Journal of cosmetic dermatology (2021)
Forough Shams, Hamideh Moravvej Farshi, Simzar Hosseinzadeh, Bahram Kazemi, Masoumrh Rajabibazl, Azam Rahimpour
Evaluation of in vitro fibroblast migration by electrospun triple-layered PU-CA/gelatin.PRGF/PU-CA scaffold using an AAVS1 targeted EGFP reporter cell line. BioImpacts : BI 12 (3) (2021)
Fahimeh Abdollahimajd, Khatere Zahedi, Zahra Asadi Kani, Hamideh Moravvej Farshi
Photoclinic: Cutaneous Metastatic Renal Cell Carcinoma. Archives of Iranian medicine 23 (12) (2020)
Mojtaba Memariani, Mojtaba Memariani, Reza Mahmoud Robati, Soheila Nasiri, Fahimeh Abdollahimajd, Zohre Baseri, Hamideh Moravvej Farshi
Anti-Staphylococcal and cytotoxic activities of the short anti-microbial peptide PVP. World journal of microbiology & biotechnology 36 (11) (2020)
Hamideh Moravvej Farshi, Fahimeh Abdollahimajd, M H Naseh, Z Piravar, E Abolhasani, N Mozafari, H Niknejad
Cultured allogeneic fibroblast injection vs. fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment. The British journal of dermatology 179 (1) (2018)